- Home
- TC vs COCH Comparison
TC vs COCH Comparison
Compare TC & COCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TC | COCH |
|---|---|---|
| Founded | 2010 | 1995 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Blank Checks |
| Sector | Consumer Discretionary | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 29.0M | 24.4M |
| IPO Year | 2018 | N/A |
Fundamental Metrics
Financial Performance| Metric | TC | COCH |
|---|---|---|
| Price | $12.50 | $0.72 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $9.50 |
| AVG Volume (30 Days) | 8.6K | ★ 461.7K |
| Earning Date | 12-16-2025 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $5,115,721.00 | $208,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $29.53 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $9.20 | $0.64 |
| 52 Week High | $39.00 | $2.06 |
Technical Indicators
Market Signals| Indicator | TC | COCH |
|---|---|---|
| Relative Strength Index (RSI) | 25.45 | 39.09 |
| Support Level | $14.43 | $0.80 |
| Resistance Level | $15.88 | $0.86 |
| Average True Range (ATR) | 1.50 | 0.05 |
| MACD | -0.54 | -0.01 |
| Stochastic Oscillator | 23.66 | 6.46 |
Price Performance
Historical ComparisonAbout TC TuanChe Limited
Token Cat Ltd is an omnichannel automotive marketplace in China. The company operates in one segment, providing auto shows, special promotion event services, virtual dealerships, online marketing services, and more. It organizes auto shows to facilitate transactions between consumers and auto dealers, which include auto dealers, automakers, and automotive service providers. It offers services through its online platform and offline events.
About COCH Envoy Medical Inc.
Envoy Medical Inc is a hearing health company focused on providing medical technologies. It is dedicated to pushing hearing technology beyond the status quo to provide patients with improved access, usability, independence and quality of life. The Company has one reportable segment: hearing. The hearing segment derives revenue from the sale of the Esteem FI-AMEI implants and replacement components to Esteem FI-AMEI implants.